BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 3)

Remdesivir update: FDA issues EUA for COVID-19 treatment days after clinical trial results

By

By NewsDesk  @infectiousdiseasenews On Wednesday, the National Institutes of Health (NIH) reported that preliminary data analysis from a clinical trial on the investigational antiviral drug, remdesivir,...

Arthritis drug, Actemra, shows promising therapeutic value for COVID-19 patients

By

UC San Diego Health has launched a Phase III clinical trial, part of a global effort, to assess whether a medication used to treat rheumatoid arthritis and other inflammatory disorders might also have...

FDA warning for Hydroxychloroquine or Chloroquine for COVID-19: Risk of Heart Rhythm Problems

By

On Friday, the US Food and Drug Administration (FDA) issued a safety alert concerning the use of hydroxychloroquine or chloroquine for the treatment of COVID-19. FDA is concerned that hydroxychloroquine...

Vaginal Yeast Infection treatment: SCYNEXIS announces positive top-line results from its second pivotal Phase 3 Study of Oral Ibrexafungerp

By

SCYNEXIS, Inc. announced this week positive top-line results for its Phase 3 VANISH-306 study investigating the safety and efficacy of oral ibrexafungerp, a novel broad-spectrum antifungal, as a treatment...

SARS-CoV-2

Hydroxychloroquine: Novartis reaches agreement with FDA to proceed with a Phase III clinical trial in hospitalized COVID-19 patients

By

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for...

Remdesivir improved majority of patients hospitalized with severe COVID-19

By

Nearly two thirds of severely ill patients hospitalized with COVID-19 who received remdesivir on a compassionate-use basis improved, with no new concerns about safety reported during the short clinical...

Japan: Influenza antiviral drug Avigan production ramped up for COVID-19

By

Kenji Sukeno, the President of FUJIFILM Corporation announced Wednesday that it has expanded its manufacturing capacity at FUJIFILM Toyama Chemical Co., Ltd. to significantly increase production of its...

Temple University: 1st US patient treated with gimsilumab in trial for patients with COVID-19 and ARDS

By

Temple University Hospital has treated the first patient in the United States in the BREATHE clinical trial evaluating the impact of intravenous treatment with gimsilumab on mortality for patients with...

Remdesivir effective against a key enzyme of coronavirus that causes COVID-19: University of Alberta researchers

By

Scientists at the University of Alberta have shown that the drug remdesivir is highly effective in stopping the replication mechanism of the coronavirus that causes COVID-19, according to new research...

COVID-19 therapies: Eli Lilly begins clinical testing for Baricitinib, Anti-Ang2

By

Eli Lilly and Company announced Friday it has entered into an agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to...